Rejuve. AI is the world's first decentralized AI longevity research network, bringing together blockchain, artificial intelligence, and longevity-focused research to dramatically increase human healthspan. Rejuve's mission is to find advanced longevity therapies and solutions and make them available and affordable to all who want them, while fairly compensating the data contributors who made these discoveries possible.
Currently, longevity is a super niche market, with its early products primarily serving the ultra-rich. The data that leads to these game-changing technologies is frequently siphoned from big tech via our everyday devices, with the general population that contributed this data reaping little to no immediate benefits.Rejuve’s unique tokenomic model will solve this problem, accurately assigning credit for contributions of data to longevity research.
Rejuve is a spin-off of SingularityNET, a decentralized marketplace for AI and ecosystem for creating beneficial artificial general intelligence (AGI). SingularityNET incubated Rejuve in 2018, and it now serves as a conduit for Bio-AI research. Longevity is a natural match for futurism/AI, with many tech enthusiasts desiring a longer life to witness the accomplishments they are striving for.
Rejuve is creating a live, interactive research database by leveraging the data of network members and partners, rewarding all constituents proportionally through the Rejuve (RJV) utility token. Our primary data collection tool and point of contact is our mobile app Longevity. This iOS and Android app allows users to input personal health data from various sources such as surveys, lab tests, and wearables in exchange for RJV tokens. This living personal health inventory will function as an electronic personal health record (ePHR), allowing Rejuve.AI and partner labs to conduct studies based on various metrics and interventions with ease.
RJV tokens can be used in the app to buy supplements, medical tests, personalized plans for living longer, and more at deeply discounted prices. RJV tokens can be earned by sharing data within the app or proceeds from the product NFT. RJV tokens can also be used to vote on how their data is used in the network and what decisions should be made about it.
Along with the RJV utility token, which will be the main form of rewards, our model also uses non-fungible tokens (NFTs) in a unique way that lets data contributors get paid fairly and in proportion to how much they contributed to a project. Two NFTs are used to make this 9 happen. The first is the Data NFT (dNFT), which is also a Rejuve ID. Each user/entity is given a unique Data NFT that is used to identify their profile.
The second NFT is the Product NFT (pNFT), which is minted every time a new product idea is proposed. It is then split into pieces or "shards" based on how much data each user contributed to that project, with only 50% of each user's shards being able to be sold. This is tied to the data NFT to make sure that each user keeps at least half of the proceeds from their data contributions.
Artificial intelligence (AI) is an important part of the Rejuve Network. It crunches data to find solutions that were not possible before. In line with precision medicine, Rejuve's built-in AI framework tries to make dynamic, multi-resolution models of the human body to learn how different substances and actions affect the whole body as a whole, taking into account key factors like DNA markers.
We will utilize neural nets, Bayesian nets, simulations, and the ongoing AGI (artificial general intelligence) engine OpenCog Hyperon as our first AI suite. This includes the Generative Cooperative Network (GCN), which is similar to the Generative Adversarial Network (GAN), but with a slightly different approach. This will allow crowdsourcing of AI models from other scientists to create a simulation based on the principles of consensus in complex adaptive systems
Once network members start sending in data along different axes, Rejuve's AI framework can start to look for patterns and connections, including the implementation of specific studies and hypotheses related to longevity, like taking a certain supplement regularly or following a certain exercise plan. When the AI analyses are done and we know what they mean, we will move on to clinical trials and the production of therapies that can be sold to Rejuve token holders at discounted prices and give them access to these solutions first.
Partnerships are a core aspect of the development of the Rejuve network. Rejuve leverages the labor and skills of individuals and businesses who want to help the cause, not only through health data contributions and AI models, but also through partnerships and collaborative efforts. While we intend to develop in-house solutions, Rejuve will collaborate with other longevity-focused supplement and test providers, apps, research organizations, biopharma companies, and others to achieve the goal of an extended healthy lifespan for all.
验证 0%
注意。未经证实的成员实际上可能不是团队成员
此优惠仅基于要约人提供的信息及其他公开信息。令牌销售或交换活动与ICO持有人完全无关,ICO持有人不参与(包括任何技术支持或促销)。仅显示ICO持有人无关的人员列出的令牌销售仅用于帮助客户跟踪总体令牌部门内发生的活动。这些信息并不意味着相当于您应该依赖的建议。在采取或不采取任何行动之前,您必须获得专业或专家的建议或进行自己的尽职调查。贡献者就收购令牌所订立的任何条款及条件属于其之间,而令牌及ICO持有人的发行人并非该等令牌的卖方。对于任何代币销售而言,ICOholder对第三方所作的任何陈述不承担任何法律责任,并且还必须直接针对此处列出的代币发行实体提出任何违反合同的请求。
如果您有任何疑问关于此令牌销售的性质,合法性或合法性或相关人员,请联系info@icoholder.com,了解有关您的疑虑的详细信息。